Keywords: roche, lamifiban, fails, meet, endpoint, hoffmann-la, revealed

Roche's lamifiban fails to meet endpoint

Article | 16 March 2000

Hoffmann-La Roche has revealed that its intravenous glycoproteinIIb/IIIa antagonist for the treatment of non-Q-wave myocardial infarction or unstable angina ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Heparin

Aspirin

Bayer

Go to drug listing